Last Updated:
Access Report
Name Designation Appointment Date Status
Manishkumar Ishwarbhai Patel

Appointed as Director since January 2014

 Director 01-Jan-2014 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Bhadreshkumar Narhariprasad Dave

Appointed as Director since March 2025

 Director 17-Mar-2025 Current

People Timeline

Explore the timeline of key personnel in Sai Siddhi Pharmachem Private Limited's leadership journey.

Contact Details
  • Address Plot No.: 126-127, G.I.D.C., Phase-Ii, Rajpipla, Dist. Narmada,, Rajpipla Gujarat, 393145, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 393145
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Sai Siddhi Pharmachem Private Limited?
You can contact Sai Siddhi Pharmachem Private Limited through their registered address at Plot No.: 126-127, G.I.D.C., Phase-Ii, Rajpipla, Dist. Narmada,, Rajpipla Gujarat, 393145, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Sai Siddhi Pharmachem Private Limited?
The current directors of Sai Siddhi Pharmachem Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • MANISHKUMAR ISHWARBHAI PATEL
  • Bhadreshkumar Narhariprasad Dave
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available